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Abstract
Background: Streptococcus suis is a major swine pathogen and zoonotic agent that mainly causes septicemia,
meningitis, and endocarditis. It has recently been suggested that proteinases produced by S. suis (serotype 2) are
potential virulence determinants. In the present study, we screened a S. suis mutant library created by the insertion
of Tn917 transposon in order to isolate a mutant deficient in a cell surface proteinase. We characterized the gene
and assessed the proteinase for its potential as a virulence factor.
Results: Two mutants (G6G and M3G) possessing a single Tn917 insertion were isolated. The affected gene coded
for a protein (SSU0757) that shared a high degree of identity with Streptococccus thermophilus PrtS (95.9%) and, to
a lesser extent, with Streptococcus agalactiae CspA (49.5%), which are cell surface serine proteinases. The SSU0757
protein had a calculated molecular mass of 169.6 kDa and contained the catalytic triad characteristic of subtilisin
family proteinases: motif I (Asp200), motif II (His239), and motif III (Ser568). SSU0757 also had the Gram-positive cell
wall anchoring motif (Leu-Pro-X-Thr-Gly) at the carboxy-terminus, which was followed by a hydrophobic domain.
All the S. suis isolates tested, which belonged to different serotypes, possessed the gene encoding the SSU0757
protein. The two mutants devoid of subtilisin-like proteinase activity had longer generation times and were more
susceptible to killing by whole blood than the wild-type parent strain P1/7. The virulence of the G6G and M3G
mutants was compared to the wild-type strain in the CD1 mouse model. Significant differences in mortality rates
were noted between the P1/7 group and the M3G and G6G groups (p < 0.001).
Conclusion: In summary, we identified a gene coding for a cell surface subtilisin-like serine proteinase that is
widely distributed in S. suis. Evidences were brought for the involvement of this proteinase in S. suis virulence.
Background
The swine pathogen Streptococcus suis is transmitted via
the respiratory route and colonizes the palatine tonsils
and nasal cavities of pigs from where it can disseminate
throughout the animal and cause infections [1], mainly
septicemia, meningitis, and endocarditis, as well as
arthritis [1]. Zoonotic infections occur mainly in indivi-
duals who work in close contact with pigs or pork by-
products [2]. In fact, S. suis is considered one of the
most important etiologic agents of adult meningitis in
Asian countries [3]. While thirty-five serotypes (1 to 34
and 1/2) have been identified based on capsular anti-
gens, serotype 2 is considered the most virulent and is
the most commonly recovered from diseased pigs and
humans [1]. Over the past ten years, numerous studies
have been undertaken to identify putative virulence fac-
tors in S. suis [1,4,5]. Among these virulence factors, the
polysaccharide capsule, which provides protection
against phagocytosis [6], appears to be essential for the
pathogenicity of S. suis. However, considering the multi-
step pathogenesis of S. suis infections, it is likely that
the virulence of this pathogen is determined by more
than one factor [7].
Proteases, which are hydrolytic enzymes that catalyze
the cleavage of peptide bonds, are critical virulence fac-
tors for numerous microbial pathogens [8]. These
enzymes hydrolyze a variety of host proteins, including
serum and tissue components, thus helping to neutralize
the host immune defense system and causing tissue
destruction and invasion [8]. Interestingly, these
enzymes show great potential as vaccine antigens and
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terial drugs [9]. A previous study in our laboratory iden-
tified four proteolytic enzymes produced by S. suis,
including one on the cell surface that degrades a chro-
mogenic substrate highly specific for chymotrypsin-like
proteases [10]. In the present study, we screened an S.
suis P1/7 (serotype 2) mutant library created by the
insertion of Tn917 transposon in order to isolate a
mutant deficient in this activity. We characterized the
gene and assessed the proteinase for its potential as a
virulence factor.
Methods
Bacteria and mutant library
S. suis P1/7, a virulent serotype 2 European reference
strain isolated from a pig with meningitis for which the
genome has been sequenced by the S. suis Sequencing
G r o u pa tt h eS a n g e rI n s t i t u t e[ 1 1 ] ,w a su s e da st h e
wild-type strain. Bacteria were routinely grown in Todd
Hewitt broth (THB; BBL Microbiology Systems, Cock-
eysville, MA, USA) at 37°C under aerobiosis. A mutant
library was constructed in a previous study [12] using
the pTV408 temperature-sensitive suicide vector to deli-
ver the Tn917 transposon into S. suis P1/7 via electro-
poration. To maintain the selective pressure during the
growth of the mutants, the culture medium was supple-
mented with 1 μg/ml of erythromycin. Escherichia coli
MC1061 (hsdR2 hsdM+ hsdS+ araD139 Δ(ara-leu)7697
Δ(lac)X74 galE15 galK16 rpsL (StrR) mcrA mcrB1),
which was used for plasmid rescue, was grown in LB
medium containing 100 μg/ml of erythromycin.
Isolation of mutants deficient in proteinase activity
Mutants from the Tn917 library were individually grown
overnight in THB and suspended in phosphate-buffered
saline (PBS, 50 mM, pH 7.2) to an optical density of 1.0
at 660 nm (OD660). Bacterial suspensions (100 μl) were
added to the wells of 96-well microplates along with 20
μl of the chromogenic substrate N-succinyl-Ala-Ala-Pro-
Phe-pNa (2 mg/ml in 50% dimethyl formamide) (Sigma-
Aldrich Canada Ltd., Oakville, ON, CANADA). This sub-
strate is highly specific for subtilisin-like [13] and chymo-
trypsin-like enzymes [14]. The reaction mixtures were
incubated at 37°C for 4 h. The release of pNA was quan-
tified by measuring the absorbance at 415 nm (A415).
Demonstration of transposon insertion and stability of
mutants
Chromosomal DNA was isolated from cells harvested
from overnight bacterial cultures as previously reported
[ 1 5 ] ,e x c e p tt h a tp r o t e i n a s e K (Sigma-Aldrich Canada
Ltd.) was used instead of protease I. The DNA was
digested with HindIII restriction endonuclease, Southern
blotted, and hybridized using a digoxigenin (DIG)-
labeled probe specific for the erm gene in the Tn917
transposon as previously reported [12]. Hybridization
was performed at 68°C, and the probe was detected
using the NBT (p-nitroblue tetrazolium chloride)/BCIP
(5-bromo-4-chloro-3-indolyl phosphate) chromogen sys-
tem. The probe was generated from pTRKL2T [16] by
PCR using the ermF 5’-ACGAGTGAAAAAGTACT
CAACC-3’ and ermR 5’-ACCTCTGTTTGTTAGG
GAATTG-3’ primers and the DIG-PCR labeling mix-
ture. The stability of the Tn917-induced mutation was
investigated by performing overnight serial passages (up
to 35) of the mutants in erythromycin-free THB prior to
measuring the hydrolysis of the chromogenic substrate
N-succinyl-Ala-Ala-Pro-Phe-pNa as described above.
Plasmid rescue and sequencing of the insertion site
The site of the transposon insertions in the S. suis P1/7
genome was determined by plasmid rescue [12]. The
genomic DNA of the selected mutants was isolated and
digested using HindIII, ligated, and transformed into
chemically competent E. coli MC1061. Transformants
were selected on LB agar containing erythromycin. Plas-
mid DNA was then extracted from the E. coli cells and
was sequenced using the Tn917 (5’-aGAGAGATGT-
CACCGTCAAGT-3’) primer to determine the DNA
sequence contiguous to Tn917.
Characterization and comparative analysis of SSU0757
The theoretical pI and molecular mass of SSU0757 were
determined using software available at http://www.scripps.
edu/~cdputnam/protcalc.html. The alignment and com-
parison of the amino acid sequences of the subtilisin-like
serine proteinases was performed using BioEdit software.
Distribution of SSU0757 in S. suis
Selected S. suis strains were tested for the presence of the
subtilisin-encoding gene (SSU0757): S428 (serotype 1),
31533 (serotype 2), 89-999 (serotype 2), S735 (serotype
2), 90-1330 (serotype 2), 65 (serotype 2), 89-4223 (sero-
type 2), 2651 (serotype 1/2), 4961 (serotype 3), Amy12C
(serotype 5), 1078212 (untypeable), and 1079277 (untype-
able). Except for strains 90-1330, 65 and 89-4223, which
were isolated from healthy pigs, all other isolates were
from diseased pigs. Cell lysates were prepared from bac-
terial colonies recovered from agar plates. The presence
of the gene was determined by PCR using the SUB163
(5’-GTCAGCGAATCAGCCTCAGAAAGTCCCGTT-3’)
and SUB4436R (5’-CTTCATCTTTTTTGTCAGTGG
CAGTATTTG-3’) primers.
Growth studies
The generation times of S. suis wild-type strain P1/7 and
the proteinase-deficient mutants were determined by
inoculating erythromycin-free THB with late-log phase
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times were calculated from the growth curves.
Susceptibility to whole blood
Venous blood samples were collected from the antecubi-
tal vein of a human volunteer using the Vacutainer™ sys-
tem and sterile endotoxin-free blood collection tubes
containing 150 IU of sodium heparin (Becton Dickinson,
Franklin Lakes, NJ, USA). Informed consent was
obtained from the donor prior to the experiment. The
protocol was approved by the Université Laval ethics
committee. S. suis (wild-type parent strain and mutants)
were cultivated to the early stationary growth phase at
37°C. The cells were harvested by centrifugation at
11,000 g for 10 min, suspended in RPMI-1640 medium
to an OD660 of 0.1, and diluted 1:100 in RPMI-1640
medium. Whole blood (1 ml) was mixed with pig serum
anti-S. suis (300 μl) and S. suis cells (100 μl). Anti-S.
suis serum was prepared in pigs by injecting whole bac-
terial cells as previously described [17]. The mixtures
were incubated for 4 h at 37°C with occasional gentle
shaking. Infected whole blood cultures were harvested at
0 and 4 h. The first time point (0 h) was considered as
the 100% viability control. Infected whole blood samples
were 10-fold serially diluted (10
-1 to 10
-4)i nP B Sa n d
plated on Todd-Hewitt agar plates. After a 24-h incuba-
tion at 37°C, the number of colony forming units (cfu)
was determined. The experiments were carried out in
duplicate.
Experimental infections in mice
Thirty-nine female six-week-old CD1 mice (Charles
River Laboratories, Saint-Constant, QC, Canada) were
acclimatized to a 12 h light/dark cycle and were given
rodent chow and water ad libitum. On the day of the
experiment, the mice (11 per group) were infected by i.
p. injection of 1 ml of either S. suis wild-type strain P1/
7o rt h eT n 917 mutants deficient in proteinase activity
at a concentration of 7 × 10
7 CFU/ml in THB. Six con-
trol mice were inoculated with the vehicle solution (ster-
ile THB) alone. The CD1 mouse has proven to be an
excellent model of S. suis infections that result in an
e a r l ys e p t i cs h o c k - l i k es y n d r o m ea n das e c o n dl a t e
phase S. suis infection that induces meningitis and brain
damage [18-20]. The septicemic phase of S. suis infec-
tions is characterized by depression, rough hair coat,
swollen eyes, weakness, and death during the first 48 h
post-infection. If animals survive this critical step of the
disease, they may still develop central nervous system
damage and meningitis, with the sudden appearance of
nervous signs beginning 3-4 days post-infection, includ-
ing hyperexcitation, episthotonus, opisthotonus, bending
of the head toward one side, and walking in circles [18].
Clinical signs of infection and survival were recorded on
a daily basis post-infection for 14 days as previously
described [18]. Mice exhibiting extreme lethargy or neu-
rological signs were considered moribund and were
humanely euthanized. All experiments involving mice
were conducted in accordance with the guidelines and
policies of the Canadian Council on Animal Care and
the principles set out in the Guide for the Care and Use
of Laboratory Animals, and were approved by the Ani-
mal Welfare Committee of Université de Montréal.
Overall survival rates for the various groups were calcu-
lated using Kaplan-Meier plots. Survival curves were
compared using the log-rank test with the Holm-Sidak
method used to analyze multiple curves. A p <0 . 0 5w a s
considered statistically significant. All analyses were per-
formed using the Sigma Plot System (v.11; Systat Soft-
ware, San Jose, CA, USA).
Results
The S. suis mutant library created by insertion of Tn917
transposon (1,200 mutants) was screened for degrada-
tion of the chromogenic substrate N-succinyl-Ala-Ala-
Pro-Phe-pNa. Three mutants (G6G, J9G, and M3G)
w e r ef o u n dt ob ed e v o i do fa c t i v i t y( A 415 < 0.05) com-
pared to parental strain (A415 = 0.85). With the objective
to show that only one transposon insertion was present
in mutants, chromosomal DNA was analyzed by South-
ern blotting using a DIG-labeled probe specific for the
erm gene in the Tn917 transposon. As shown in Figure
1, only one Tn917 insertion occurred in the G6G and
M3G mutants. Since the J9G mutant had two insertions,
we only used the G6G and M3G mutants for further
experiments. The mutations were highly stable, with
G 6 Ga n dM 3 Gs t i l lu n a b l et od e g r a d et h ec h r o m o g e n i c
substrate after 35 serial transfers in liquid medium (ery-
thromycin-free).
To identify which gene was inactivated in mutants, the
Tn917 insertion sites in G6G and M3G were sequenced.
The affected gene corresponded to a gene coding for
t h eS S U 0 7 5 7p r o t e i ni nt h eg e n o m eo fS. suis P1/7
based on a comparison of the sequence with those of
the S. suis Sequencing Group at Sanger Institute. In
mutant G6G, the transposon inserted at position 2,657
while in mutant M3G, it inserted at position 3,132. The
analysis of the chromosomal region contiguous to the
Tn917-inactivated gene confirmed that SSU0757 is not
part of an operon. This and the transcriptional orienta-
tions of the contiguous genes suggested that there were
no transposon-induced effects (Figure 2). This gene had
a 4,758-nucleotide ORF and a G+C content of 41.64%,
which was very similar to that of the S. suis genome
(38-42%) [21]. There were also a transposase upstream
and a sugar kinase downstream from the gene (Figure
2). To further explore the distribution of this gene in S.
suis, we performed PCR assays using internal primers
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DNA isolated from 11 strains belonging to serotypes 1,
1/2, 2, 3, and 5. Two untypeable isolates were also
included. As shown in Figure 3, the gene was detected
in all the strains tested, suggesting that it is widely
distributed.
An in silico analysis of the SSU0757 gene product was
performed to determine principal characteristics of the
protein. This revealed that it corresponds to a 1,585-
residue polypeptide with a predicted pI of 4.58 and a
calculated molecular mass of 169.6 kDa. The protein
contained the catalytic triad characteristic of subtilisin
family proteinases: motif I (Asp200), motif II (His239),
and motif III (Ser568). It also contained the Gram-posi-
tive cell wall anchoring motif (Leu-Pro-X-Thr-Gly) at
the carboxy-terminus at positions 1551-1555 followed
by a hydrophobic domain as well as an amino-terminal
signal sequence with a putative cleavage site between
residues 35 and 36 (Figure 2).
The alignment and comparison of the amino acid
sequences of SSU0757 with known streptococcal subtili-
sin-like serine proteinases was performed using BioEdit
software. The amino acid sequence of SSU0757 had a
degree of identity of 98.9% and 98.4% with those of
strains 05ZYH33 and 98HAH33, respectively. A data-
base search revealed that the amino acid sequence of
SSU0757 shared a high degree of identity (95.9%) with
PrtS of Streptococccus thermophilus, which codes for a
cell surface subtilisin-like proteinase (Table 1). As
reported in Table 1, the SSU0757 protein shared signifi-
cant identity with other streptococcal subtilisin-like
proteinases. After the PrtS of S. thermophilus, the sec-
ond highest degree of identity (49.5%) was with the
CspA of Streptococcus agalactiae, which also codes for a
cell surface subtilisin-like proteinase [22].
The role of the subtilisin-like proteinase of S. suis in
nutrition was investigated by comparing the growth of the
wild-type strain in THB with that of the Tn917 mutants.
Table 2 lists the generation times for each strain. The two
proteinase-deficient mutants had longer generation times
than the wild-type strain. The impact of inactivating the
proteinase on the survival of S. suis in human whole blood
was also tested. As shown in Figure 4, the percent survival
rate of the wild-type parent strain was 42.6 after a 4-h
incubation in whole blood. The two mutants were much
more sensitive, with a percent survival percent rate of 22.1
for G6G and 4.4 for M3G.
The virulence of the G6G and M3G mutants was
compared to the wild-type strain in the CD1 mouse
model. All the animals in the P1/7 group presented
severe clinical signs associated with septicemia and sep-
tic shock, including rough hair coat, depression, and
prostration during the first 72 h post-infection. Four
mice died from septicemia in this group (36.4%) (Table
3). From days 5-10, the rest of the mice infected with
the P1/7 strain (63.6%) (Table 3) developed clear signs
of neurological and/or vestibular symptoms, including
hyperexcitation, episthotonus, opisthotonus, lateral
bending of the head, walking in circles, rolling, and
spinning [18]. Mice with these clinical signs were sacri-
ficed for ethical reasons. M3G and G6G mice presented
only mild clinical signs of a S. suis infection during the
first 48 h post-infection, which mainly consisted of
rough hair coat. Mice from both groups returned to
their normal behavior after this period. Surprisingly,
from days 11-13 post-infection, three mice from the
M3G group (27.3%) died (Table 3). At this late stage of
the trial, these deaths might have been due to either
sub-clinical meningitis or endocarditis [18]. No deaths
were recorded in the G6G group (Table 3). It is worth
noting that S. suis was recovered from all the mice,
whatever the group, that died either of septicemia or
meningitis (data not shown). Survival curves for the var-
ious groups were analyzed using Kaplan-Meier plots and
compared using the log-rank test with the Holm-Sidak
method for analyzing multiple curves. Significant differ-
ences in mortality rates were noted between the P1/7
group and the M3G and G6G groups (p < 0.001) (Figure
5). In contrast, there were no statistical differences in
mortality rates between the M3G and G6G groups (p >
0.05) (Figure 5).
Discussion
Bacterial pathogens possess various surface proteins,
most of which are virulence determinants involved in
1     2      3     4
6.1 kb
3 kb
2 kb
1.6 kb
1 kb
Figure 1 Southern blot of S. suis P1/7 and the Tn917 mutants.
Chromosomal DNA was digested with HindIII restriction
endonuclease and hybridized with a DIG-labeled probe specific for
the erm gene. Lane 1, wild-type parent strain P1/7; lane 2, mutant
J9G; lane 3, mutant M3G; lane 4, G6G.
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the present study, we identified a S. suis gene that codes
for a cell surface subtilisin-like proteinase containing the
cell wall sorting signal LPXTG that is responsible for
covalently anchoring proteins to cell wall peptidoglycan.
The sortase A previously identified in S. suis has been
reported to play an important role in anchoring LPXTG
proteins to the cell wall [23] and may be involved in
locating the subtilisin-like proteinase on the cell surface.
A number of potential virulence factors previously char-
acterized in S. suis, including the opacity factor [24], the
virulence marker MRP [25], the surface antigen one
[26], and a surface protein associated with invasion of
porcine brain endothelial cells [20], contain the anchor-
ing motif LPXTG,.
The cell surface subtilisin-like proteinase of S. suis
showed the highest identity with the PrtS of S. thermo-
philus (95.9%) and the CspA of S. agalactiae (49.5%). In
the dairy lactic bacterium S. thermophilus, the PrtS sub-
tilisin-like proteinase degrades casein into peptides,
which are required for efficient growth [27,28]. S. aga-
lactiae is a major causal agent of mastitis in cattle [29]
and is the principal cause of neonatal meningitis [30].
The CspA subtilisin-like proteinase of this pathogenic
streptococcus is considered to be a critical virulence fac-
tor [22]. This proteinase has been shown to be involved
Figure 2 Alignment of the catalytic triad (Asp200 -H i s 239 - Ser568; indicated by arrows) of S. suis SSU057 and homologous
streptococcal subtilisin-like proteinases. Each catalytic triad is identified by UniProtKB accession numbers: A4VUI8 + A4VUI9 correspond to S.
suis 05ZYH33 (SSU05-0811 + SSU05-0812); A4WOT0 + A4WOT1 correspond to S. suis 98HAH33 (SSU98-0811 + SSU98-0812); Q9F8Q4 corresponds
to S. thermophilus PrtS; Q3JYS0 corresponds to S. agalactiae CspA; A3CQ08 corresponds to S. sanguinis PrtS; Q9A180 corresponds to S. pyogenes
PrtS; Q3HV58 corresponds to S. pyogenes ScpC; P15926 corresponds to S. pyogenes ScpA; Q3K0M1 corresponds to S. agalactiae ScpB; Q04LP0
corresponds to S. pneumoniae PrtA.
4 kb
5 kb
1 2    3  4  5    6  7    8   9   10 11   12  13  14
Figure 3 Distribution of the gene coding for the SSU0757 protein in various S. suis strains. Lane 1, DNA molecular weight markers; lane 2,
S428 (serotype 1); lane 3, P1/7 (serotype 2); lane 4, 90-1330 (serotype 2); lane 5, S735 (serotype 2); lane 6, 65 (serotype 2); lane 7, 31533 (serotype
2); lane 8, 89-4223 (serotype 2); lane 9, 89-999 (serotype 2); lane 10, 2651 (serotype 1/2); lane 11, 4961 (serotype 3); lane 12, Amy12C (serotype 5);
lane 13, 1078212 (untypeable); lane 14, 1079277 (untypeable).
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in resistance to opsonophagocytic killing by human neu-
trophils in vitro [22]. More recently, the CspA of S. aga-
lactiae has been shown to hydrolyze and inactivate CXC
chemokines, many of which can recruit neutrophils to
sites of infection [31].
Bacterial pathogenicity is a complex process that
depends on the ability of the pathogen to multiply. The
S. suis subtilisin-like proteinase appears to contribute to
nutrient acquisition given that proteinase-deficient
mutants had longer generation times than the parent
strain in vitro. This is consistent with the study of Cour-
tin et al. [28], who reported that the PrtS subtilisin-like
proteinase of S. thermophilus is involved in nitrogen
supply through casein hydrolysis. The mutants and the
wild type strain were also compared for their ability to
survive in human whole blood. We found that the par-
ent strain was much more resistant to killing than the
mutants. This suggests that the proteinase may degrade
human serum proteins with bactericidal activity or opso-
nins involved in phagocytosis by immune cells. This is
in agreement with the study of Harris et al. [22], who
reported that the CspA subtilisin-like proteinase of S.
agalactiae, which shares a high degree of identity with
S. suis, contributes to the resistance to phagocytosis by
neutrophils.
Given its cell surface localization, the subtilisin-like
proteinase of S. suis may interact with host cells and
induce an inflammatory response which is a feature of
meningitis. Indeed, the S. suis proteinase may activate
protease-activated receptors (PAR), which are members
of the G protein-coupled receptors also known as
seven-transmembrane domain receptors [32]. These
receptors are found on several cell types and play an
important role in inflammatory processes. More speci-
fically, PAR-2 is known to be activated by serine pro-
teases and bacterial proteinases [33]. Since S. suis cells
are known to induce the production of pro-inflamma-
tory cytokines by endothelial cells [34] and macro-
phages [35], part of this activation may be caused by
the cell surface subtilisin-like proteinase identified in
this study. Studies are currently in progress in our
laboratory to verify this hypothesis. In a previous
study, we reported that the presence of fibrinogen dur-
ing growth of S. suis modulates its capacity to form a
biofilm [36]. Given the ability of bacterial subtilisin-
like proteinases to degrade fibrinogen [22,37,38], it
may be hypothesized that the proteinase of S. suis
could cleave fibrinogen leading to generation of fibrin,
which may favor biofilm formation.
The contribution of the subtilisin-like proteinase to
virulence was investigated in a mouse model. We found
Table 1 Percentage identity of the amino acid (a.a.)
sequences of S. suis P1/7 SSU0757 with proteinases from
other streptococcal species.
Bacterial species Accession no. Predicted a.a. sequence %
identity
S. suis uncharacterized
protein
A4VUI8 +
A4VUI9
98.9
S. suis uncharacterized
protein
A4WOT0 +
A4WOT1
98.4
S. thermophilus PrtS Q9F8Q4 95.9
S. agalactiae CspA Q3JYS0 49.5
S. sanguinis PrtS A3CQ08 40.6
S. pyogenes PrtS Q9A180 31.8
S. pyogenes ScpC Q3HV58 31.8
S. pyogenes ScpA P15926 24.0
S. agalactiae ScpB Q3K0M1 23.6
S. pneumoniae PrtA Q04LP0 16.2
Table 2 Generation times of S. suis P1/7 and the Tn917
mutants deficient in the cell surface subtilisin-like
proteinase.
Strain Generation time in minutes
(mean ± standard deviation)
P1/7 45.3 ± 6.9
M3G 57.6 ± 8.2
G6G 55.8 ± 4.8
Figure 4 Survival of S. suis wild-type strain P1/7 and mutants
M3G and G6G in human whole blood. Mixtures were incubated
at 37°C for 4 h. A value of 100% was given to the colony forming
units at time 0. Results are representative of two assays.
Table 3 Virulence in CD1 mice of S. suis wild-type strain
P1/7 and mutants M3G and G6G.
Strain Death (%)* Total mortality
(%)
Septicemia Meningitis
P1/7 36.4 63.6 100
M3G 0 27.3 27.3
G6G 0 0 0
* Eleven mice were infected per group and measurements were performed
over a 14-day period post-infection. Percent of animals that died due to an
infection or that were sacrificed for ethical reasons.
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icantly less virulent in mice. This clearly suggests that
the S. suis subtilisin-like proteinase is an virulence
determinant. Ge et al. [39] recently constructed a dipep-
tidyl peptidase IV deficient-mutant of S. suis and pro-
vided evidence for the critical role of this enzyme in the
virulence of S. suis in a mouse model. This cell surface
enzyme cleaves X-Pro/Ala dipeptides from the N-termi-
nus of proteins but also possesses binding domains for
fibronectin [39]. Given the involvement of the cell sur-
face subtilisin-like serine proteinase in S. suis virulence,
studies are in progress to clone this proteinase and
determine whether it may represent a promising candi-
date for a protein-based vaccine.
Conclusion
In summary, we identified a gene that codes for a cell
surface subtilisin-like serine proteinase and that is
widely distributed in S. suis strains. Evidences were
brought for the involvement of this proteinase in S. suis
virulence.
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